Risk-Based Prioritization of CAPA: Focusing on High-Impact Issues
Risk-Based Prioritization of CAPA: Focusing on High-Impact Issues Effective Risk-Based Prioritization of CAPA: A Step-by-Step Guide for Pharmaceutical Quality Systems The pharmaceutical industry operates in a highly regulated environment requiring strict adherence to Good Manufacturing Practice (GMP). One of the critical pillars ensuring product quality and patient safety is the implementation of a robust pharmaceutical…
Read More “Risk-Based Prioritization of CAPA: Focusing on High-Impact Issues” »